Mr Brian Leedman is an experienced biotechnology entrepreneur with over 15 years’ experience in the biotechnology industry. Mr Leedman is the founder of ResApp Health Limited where Mr Leedman served as the executive director of corporate affairs. ResApp Health Limited was acquired by Pfizer (Aust) in 2022. Mr Leedman is an experienced public company director having formerly been the chairman of Neurotech International Limited, Nutritional Growth Solutions Limited, Neuroscientific Biopharmaceuticals Limited and was a director of Alcidion Corporation Limited, Oncosil Medical Limited and Respiri Limited.
Meet the rest of our team!
With the roots of our company lying in the neurological research field, our team is built from strong academic knowledge gained at prestigious institutions such as Princeton University and Erasmus MC.